{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:00:55Z","timestamp":1791558055066,"version":"4.3.4"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0120370","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T16:15:36Z","timestamp":1427213736000},"page":"e0120370","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis"],"prefix":"10.1371","volume":"10","author":[{"given":"Carolina","family":"Garcia-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Peghin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Ruiz-Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Royo-Cebrecos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rosell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi Puig","family":"de la Bellacasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Ayats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"DP Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tid.12060","article-title":"Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience","volume":"15","author":"D Neofytos","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mould infections in allogenic stem cell transplant recipients: biological risk factors for infection according to time after transplant","volume":"47","author":"C Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"PG Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"A Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Y Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry","volume":"48","author":"D Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1634\/theoncologist.2010-0290","article-title":"Outcomes analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles","volume":"16","author":"E Ramos","year":"2011","journal-title":"The oncologist"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"B Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref10","article-title":"<italic>Manual of the International Statistical Classification of Diseases<\/italic>, <italic>Injures<\/italic>, <italic>and Causes of Death<\/italic>","year":"1977"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"W Steinbach","year":"2012","journal-title":"J Infect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"R Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis. A randomized trial","volume":"162","author":"K Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"T Dagenais","year":"2009","journal-title":"Clin Microbiol Rew"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QCO.0b013e32835fb920","article-title":"Pathogenesis of invasive fungal infections","volume":"26","author":"C Garcia-Vidal","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","author":"B Segal","year":"2009","journal-title":"N Eng J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/EC.00274-07","article-title":"Aspergillus fumigatus: principles of pathogenesis and host defense","volume":"6","author":"TM Hohl","year":"2007","journal-title":"Eukaryot Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"J Wingard","year":"2008","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT","volume":"349","author":"DG Julian","year":"1997","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archinte.162.9.1059","article-title":"Causes of death for patients with community-acquired pneumonia","volume":"162","author":"E Mortensen","year":"2002","journal-title":"Arch Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0120370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:53:36Z","timestamp":1588960416000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0120370"}},"subtitle":[],"editor":[{"given":"David N","family":"Fredricks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0120370","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725401905.793505461","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}